What You Should Know:
– Predoc, a new AI-native platform for Health Information Management secures $30M in Series A and seed funding led by Base10 Partners, with additional participation from Northzone, ENIAC Ventures, and ERA Ventures. The seed funding also included angel investments from founders of notable healthcare companies like Flatiron Health and Datavant.
– Founded by Nishant Hari, Dr. Kaushal Kulkarni, Dr. Priya Mehta, and Alex Daniels, Predoc is on a mission to challenge previous failures in interoperability and connect and organize the nation’s fragmented healthcare data using a unique AI-services approach.
Intelligent Automation for Clinical Workflows
Predoc’s platform replaces traditional, manual Health Information Management with intelligent, end-to-end automation. The solution connects and transforms all formats and sources of clinical data, including faxed medical record PDFs, into easily digestible clinical insights. Unlike existing solutions, Predoc fits within existing healthcare workflows and delivers a full-stack solution built by a team with deep clinical, technical, and operational expertise.
The company has already seen significant growth, with a 700% year-over-year increase in revenue. The Oncology Institute, one of Predoc’s customers, has seen a 75% reduction in record retrieval turnaround time, which has helped patients navigating life-changing diagnoses. The company is already supporting top oncology groups, research networks, and virtual care providers, reducing downstream clinical review time by as much as 70%.
Expansion Plans
The new capital will be used to fuel Predoc’s expansion into additional Health Information Management workflows and new enterprise healthcare organizations. As healthcare professionals demand the same ease of use and intelligence they experience in consumer tools, Predoc is setting a new standard.
“Point solutions tackling this workflow have largely failed to deliver on their promised efficiency gains, and few have unlocked the holy grail of headcount resource reallocation, improved clinical outcomes, or faster clinical trial enrollment,” added CEO, Nish Hari. “That’s why we are building Predoc, to completely offload this painful, messy workflow from our customers, so they can focus on fulfilling their core purpose – to improve human health.”
